MAJI OTC
Nextel Medical Corp.
1W: -22.4%
1M: -41.5%
3M: -52.5%
YTD: -93.1%
$0.00
-0.00 (-10.00%)
Weekly Expected Move ±35.2%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.2M
52W Range0.0017-0.17
Volume534,600
Avg Volume1,063,129
Beta-4.75
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEODonald J. Steinberg
Employees1
SectorHealthcare
IndustryBiotechnology
IPO Date2012-02-09
Websiteexousiapro.com
7901 4th Street N #23494
Saint Petersburg, FL 33702
US
Saint Petersburg, FL 33702
US
239 273 3344
About Nextel Medical Corp.
Nextel Medical Corp., a clinical stage biotechnology company, develops ways to exploit the therapeutic potential of exosomes for the field of oncology in the United States. The company was formerly known as Exousia Pro, Inc. and changed its name to Nextel Medical Corp. in April 2026. Nextel Medical Corp. was incorporated in 2010 and is based in Saint Petersburg, Florida.
Latest News
NexTel Medical Corp. Amends Previously Announced Acquisition to Acquire Island 40 Group and Full Subsidiary Platform
NexTel Medical Outlines its Revenue Model Using the Innovation of Tomorrow: Synergy of Advanced Medical Technologies and Massive Sales Infrastructure Primed to Drive Exponential Growth
NexTel Medical Corp. Announces Groundbreaking, First-of-Its-Kind Exosome Characterization Study with Penn State University
NexTel Medical Corp. Announces Groundbreaking, First-of-Its-Kind Exosome Characterization Study with Penn State University
NexTel Medical Corp. Executes Definitive Purchase Agreements to Acquire JumpstartRx and NueVistraMed, Expanding Telehealth Footprint and Accelerating Maxasome™ Commercialization
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| GRN Funds, LLC | 0 | — | 2019-06-25 | |
| Ross Donald | S-Sale | 16,500,000 | $0.01 | 2013-06-06 |
| Cutler David J | A-Award | 150,000 | — | 2013-04-09 |
| FLECHNER STEPHEN E | A-Award | 300,000 | — | 2013-04-09 |
| FLECHNER STEPHEN E | A-Award | 250,000 | — | 2013-01-21 |